DVA (DaVita) Equivalent Admissions # : 0.00 (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is DaVita Equivalent Admissions #?

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for DaVita's Equivalent Admissions # or its related term are showing as below:

DVA's Equivalent Admissions # is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

DaVita Equivalent Admissions # Historical Data

The historical data trend for DaVita's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Equivalent Admissions # Chart

DaVita Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Equivalent Admissions #

Get a 7-Day Free Trial

No of Hospitals Facilities #

Get a 7-Day Free Trial

No of Surgeries Procedures #

Get a 7-Day Free Trial

DaVitaQuarterly Data

Trend

Jun20

Sep20

Dec20

Mar21

Jun21

Sep21

Dec21

Mar22

Jun22

Sep22

Dec22

Mar23

Jun23

Sep23

Dec23

Mar24

Jun24

Sep24

Dec24

Mar25

Equivalent Admissions #

Get a 7-Day Free Trial

No of Hospitals Facilities #

Get a 7-Day Free Trial

No of Surgeries Procedures #

Get a 7-Day Free Trial

Competitive Comparison of DaVita's Equivalent Admissions #

For the Medical Care Facilities subindustry, DaVita's Equivalent Admissions #, along with its competitors' market caps and Equivalent Admissions # data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Equivalent Admissions #

Comparable Companies

Traded in Other Exchanges

0I7E:UK TRL:Germany TRL:Germany DVAI34:Brazil

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Executives

Berkshire Hathaway Inc	10 percent owner	3555 FARNAM STREET, OMAHA NE 68131
Javier Rodriguez	officer: Chief Executive Officer, DKC	601 HAWAII ST., EL SEGUNDO CA 90245
Joel Ackerman	officer: Chief Financial Officer	COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Michael David Staffieri	officer: Chief Operating Officer, DKC	2000 16TH STREET, DENVER CO 80202
Kathleen Alyce Waters	officer: Chief Legal Officer	C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Barbara J Desoer	director	CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty	officer: Chief Compliance Officer	2000 16TH STREET, DENVER CO 80202
Christopher Michael Berry	officer: Chief Accounting Officer	C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Wendy Lee Schoppert	director	6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale	director
Charles Berg	director, officer: Executive Chair, DMG	48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra	director	1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter	director	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jason M. Hollar	director	3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price	director	ONE CVS DRIVE, WOONSOCKET RI 02895